Lan Huang
Chief Executive Officer chez BEYONDSPRING INC.
Fortune : 36 M $ au 31/03/2024
Profil
Lan Huang is the founder of Dalian Wanchun Biotechnology Co. Ltd.
(2010), Paramax International, Inc. (2008), BeyondSpring, Inc. (2013), and Wuxi Mtlh Biotechnology Co. Ltd.
(2007).
She is also the founder of Seed Therapeutics, Inc., Seed Therapeutics, Inc. (Pennsylvania).
Currently, Dr. Huang is the Chairman & Chief Executive Officer at BeyondSpring Pharmaceuticals, Inc. She previously held the position of Trustee at Lawrence University (2012-2015).
Dr. Huang received her undergraduate degree from Lawrence University and her doctorate from the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BEYONDSPRING INC.
26,17% | 31/12/2023 | 10 210 523 ( 26,17% ) | 36 M $ | 31/03/2024 |
Postes actifs de Lan Huang
| Sociétés | Poste | Début |
|---|---|---|
| BEYONDSPRING INC. | Chief Executive Officer | 01/11/2014 |
Wuxi Mtlh Biotechnology Co. Ltd.
 Wuxi Mtlh Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Wuxi Mtlh Biotechnology Co. Ltd. is a private company based in Wuxi, China that develops anti-cancer drugs. The Chinese company was founded by Lan Huang and Lan Huang has been the CEO since incorporation. | Chief Executive Officer | 01/01/2010 |
BeyondSpring Pharmaceuticals, Inc.
 BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The private company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Chief Executive Officer | - |
| Seed Therapeutics, Inc.(Pennsylvania) | Chief Executive Officer | - |
| Seed Therapeutics, Inc. | Chief Executive Officer | - |
Anciens postes connus de Lan Huang
| Sociétés | Poste | Fin |
|---|---|---|
| Lawrence University | Director/Board Member | 01/01/2015 |
| Dalian Wanchun Biotechnology Co. Ltd. | Founder | - |
Paramax International, Inc.
 Paramax International, Inc. Medical/Nursing ServicesHealth Services Part of ICON plc, Paramax International, Inc. is a Chinese company that provides clinical research services. The private company is based in Beijing, China. The company was founded by Lan Huang. Paramax International was acquired by ReSearch Pharmaceutical Services LLC, part of ICON plc from August 21, 2013 on July 07, 2009 for $1.53 million. | Founder | - |
Formation de Lan Huang
| Lawrence University | Undergraduate Degree |
| University of California, Berkeley | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
BeyondSpring Pharmaceuticals, Inc.
BeyondSpring Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of BeyondSpring, Inc., BeyondSpring Pharmaceuticals, Inc. is a clinical-stage bio-pharmaceutical company that develops innovative immuno-oncology cancer therapies. The private company is based in New York, NY. The company has a robust pipeline from internal development and collaboration with the University of Washington in de novo drug discovery using a ubiquitination platform. The CEO of the company is Lan Huang. | Health Technology |
| BeyondSpring, Inc. | |
Wuxi Mtlh Biotechnology Co. Ltd.
Wuxi Mtlh Biotechnology Co. Ltd. Pharmaceuticals: MajorHealth Technology Wuxi Mtlh Biotechnology Co. Ltd. is a private company based in Wuxi, China that develops anti-cancer drugs. The Chinese company was founded by Lan Huang and Lan Huang has been the CEO since incorporation. | Health Technology |
| Dalian Wanchun Biotechnology Co. Ltd. | |
| Seed Therapeutics, Inc. | |
| Seed Therapeutics, Inc.(Pennsylvania) | |
Paramax International, Inc.
Paramax International, Inc. Medical/Nursing ServicesHealth Services Part of ICON plc, Paramax International, Inc. is a Chinese company that provides clinical research services. The private company is based in Beijing, China. The company was founded by Lan Huang. Paramax International was acquired by ReSearch Pharmaceutical Services LLC, part of ICON plc from August 21, 2013 on July 07, 2009 for $1.53 million. | Health Services |
